Home/Filings/4/0000790051-21-000145
4//SEC Filing

Roche Robert M. 4

Accession 0000790051-21-000145

CIK 0000790051other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:34 PM ET

Size

9.9 KB

Accession

0000790051-21-000145

Insider Transaction Report

Form 4
Period: 2021-05-26
Roche Robert M.
VP & Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2021-05-26$192.00/sh6,550$1,257,60025,487 total
  • Exercise/Conversion

    Common Stock

    2021-05-26$105.03/sh+6,130$643,83431,617 total
  • Sale

    Common Stock

    2021-05-26$192.26/sh6,130$1,178,55425,487 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2021-05-266,1300 total
    Exercise: $105.03Exp: 2027-02-14Common Stock (6,130 underlying)
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $192.25 to $192.43. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  • [F2]The options vested in three equal annual installments beginning on February 15, 2018.
  • [F3]The transaction is the exercise of a derivative security.

Issuer

CARLISLE COMPANIES INC

CIK 0000790051

Entity typeother

Related Parties

1
  • filerCIK 0001698243

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:34 PM ET
Size
9.9 KB